Clinical trial
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older…
NCT00246935 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00246935 |
|---|---|
| Title | Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08) |
| Official title | A Long-term Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Drug |
| Interventions | Roflumilast |
| Enrollment | 150 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Nov 1, 2005 |
| Last update posted | Oct 26, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: